×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Clearmind Medicine CEO Issues Letter to Shareholders
Yahoo Finance
Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”),...
1 month ago
Why Clearmind Medicine Stock Is Moving Higher - Clearmind Medicine (NASDAQ:CMND)
Benzinga
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research...
1 week ago
Clearmind licenses psychedelic compounds for mental disorders
Pharmaceutical Technology
Clearmind Medicine has entered into a licensing agreement with Yissum to develop Generation 3.0 psychedelic compounds for mental disorders.
1 month ago
Clearmind Applies to Cease Being a Reporting Issuer in Canada
Morningstar
Vancouver, Canada, April 30, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) ("Clearmind" or the...
2 weeks ago
Clearmind advances alcohol substitute beverage program By Investing.com
Investing.com
VANCOUVER, Canada - Clearmind Medicine Inc. (NASDAQ:CMND), a biotech firm specializing in psychedelic-derived therapeutics,...
6 days ago
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities ...
Yahoo Finance
Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company")...
2 months ago
Clearmind Medicine Completed Type A Meeting with the FDA
Yahoo Finance
Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind”...
4 months ago
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
Yahoo Finance
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19,...
1 month ago
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Yahoo Finance
For the first time, patients with alcohol use disorder will receive the company's unique and proprietary psychedelic - MEAI Vancouver,...
2 months ago
Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment
Yahoo Finance
"These results, previously announced, offer a beacon of hope, demonstrating the potential efficacy of MEAI in reducing cocaine-related...
5 months ago